bioRxiv
Sotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM Mice
Preprint: experiments in miceAtherosclerosis
Papers by Keith Saum
2 results
- ADA Scientific Sessions 2025 Abstract
The Ketone Body β-hydroxybutyrate Mitigates Diabetic Kidney Disease through Metabolic Reprogramming
Experiments in animalsInterventions